1. Home
  2. INM vs FTAIM Comparison

INM vs FTAIM Comparison

Compare INM & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • FTAIM
  • Stock Information
  • Founded
  • INM 1981
  • FTAIM N/A
  • Country
  • INM Canada
  • FTAIM United States
  • Employees
  • INM N/A
  • FTAIM 580
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • FTAIM Misc Corporate Leasing Services
  • Sector
  • INM Health Care
  • FTAIM Industrials
  • Exchange
  • INM Nasdaq
  • FTAIM Nasdaq
  • Market Cap
  • INM 3.2M
  • FTAIM N/A
  • IPO Year
  • INM N/A
  • FTAIM N/A
  • Fundamental
  • Price
  • INM $3.00
  • FTAIM $25.65
  • Analyst Decision
  • INM
  • FTAIM
  • Analyst Count
  • INM 0
  • FTAIM 0
  • Target Price
  • INM N/A
  • FTAIM N/A
  • AVG Volume (30 Days)
  • INM 56.6K
  • FTAIM N/A
  • Earning Date
  • INM 05-13-2025
  • FTAIM N/A
  • Dividend Yield
  • INM N/A
  • FTAIM N/A
  • EPS Growth
  • INM N/A
  • FTAIM N/A
  • EPS
  • INM N/A
  • FTAIM N/A
  • Revenue
  • INM $4,832,013.00
  • FTAIM N/A
  • Revenue This Year
  • INM N/A
  • FTAIM N/A
  • Revenue Next Year
  • INM N/A
  • FTAIM N/A
  • P/E Ratio
  • INM N/A
  • FTAIM N/A
  • Revenue Growth
  • INM N/A
  • FTAIM N/A
  • 52 Week Low
  • INM $1.72
  • FTAIM N/A
  • 52 Week High
  • INM $15.70
  • FTAIM N/A
  • Technical
  • Relative Strength Index (RSI)
  • INM 62.76
  • FTAIM 48.76
  • Support Level
  • INM $2.56
  • FTAIM $25.45
  • Resistance Level
  • INM $3.05
  • FTAIM $25.74
  • Average True Range (ATR)
  • INM 0.27
  • FTAIM 0.37
  • MACD
  • INM 0.09
  • FTAIM 0.05
  • Stochastic Oscillator
  • INM 92.98
  • FTAIM 76.61

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.

Share on Social Networks: